Organizations

Canadian Organization for Rare Disorders

Canadian Organization for Rare Disorders has met with MPs 5 times since January 2024, reaching 5 MPs across 3 parties. Most recent contact: July 30, 2026.

5 meetings since 20249 all-time5 MPs3 parties0% by in-house staff

What they're asking for

In the registry's own words. Descriptions are only filed for meetings since mid-2024.

  1. Enhancement to Canada's regulatory and funding environment for new rare disease medicines, including Health Canada authorizations of medicines and framework for clinical trials, health technology assessment processes, reimbursement negotiations and funding decisions to improve access for rare disease patients

    July 30, 2026 · Raquel Dancho · Conservative · Health; Industry; Intellectual Property; Science and Technology; Budget

  2. Enhancement to Canada's regulatory and funding environment for new rare disease medicines, including Health Canada authorizations of medicines and framework for clinical trials, health technology assessment processes, reimbursement negotiations and funding decisions to improve access for rare disease patients.

    May 26, 2026 · Helena Jaczek · Liberal · Health; Industry; Intellectual Property; Science and Technology; Budget

  3. Establish Innovation, Science and Economic Development Canada policies related to research and development of treatments for rare disorders

    October 10, 2025 · Luc Thériault · Bloc Québécois · Health; Industry; Science and Technology; Budget; Research and Development

Full meeting log

5 MP-directed communications since January 2024, from the Registry of Lobbyists.

DateMP
2026-07-30Raquel Dancho · Conservative
2026-06-04Tom Kmiec · Conservative
2026-05-26Helena Jaczek · Liberal
2026-05-26Marcus Powlowski · Liberal
2025-10-10Luc Thériault · Bloc Québécois
Counts include only communications where a sitting MP is the named public office holder — meetings with ministers' staff, senators, or departments are not shown. Registrants self-report these records. See our methodology.